UMass Medical School among top research enterprises, according to new ranking

UMass Medical School Communications

October 20, 2016

For the life sciences measurement, the National Taiwan University Ranking considers research publications in a number of specialties in which UMMS displays considerable strength.

UMass Medical School has been identified as having one of the strongest university-based life sciences research enterprises in the world, according to a new ranking.

The National Taiwan University Ranking, released this month, ranked UMMS 77th out of the world’s top 500 public and private universities in the field of life sciences, a jump of 12 spots over the previous year.

The report is based on an analysis and evaluation of the collective productivity, impact and excellence of a university’s published scientific papers. Productivity accounts for 25 percent of the ranking; the impact of scientific discoveries is weighted at 35 percent; and the excellence of the work accounts for the remaining 40 percent.

The life sciences measurement considers research publications in a number of specialties in which UMMS displays considerable strength, including biology and biochemistry; immunology; microbiology; neuroscience; molecular biology; genetics; pharmacology; and toxicology.

UMMS was ranked 180th in the field of clinical medicine.

The NTU ranking was first conducted in 2007 and is also known as the Performance Ranking of Scientific Papers for World Universities. The universities ranked at the top of the 2016 list are Harvard University, Johns Hopkins University and the University of California—San Francisco, respectively.

The NTU ranks approximately 500 global universities devoted to scientific research, based entirely on scientific papers.